StocktoberFest: Walgreen Co. (WAG)

October 1, 2014

wag1

Horowitz & Company’s proprietary Fundamental Scoring System (F|score) takes into consideration many factors related to each company’s financial history and outlook. This system is oriented toward a growth model and therefore will give a higher score to those companies which continually show increasing earnings per share and revenue over time. Over the long-run (and when looking to purchase a security) we prefer companies with a track record of growth and solid fundamentals. In the short-term however, it is price / technicals that pay. When investing, we combine both of these analyses to seek out possible investment opportunities within our universe of stocks.

This stock ranks below average in fundamentals and would not be considered an option that we would invest in the long-term. For those with a higher risk tolerance, it is possible to enter a speculative position with caution as this market has been much about bottom feeding on the worst of the worst companies. See below for details on where this company thrives and possibly some of the drawbacks:

We find that EPS Growth on a Quarter over Quarter basis is one of the strongest components when screening for growth stocks. Continued EPS Growth in a company generally shows strength in leadership, the ability to manage expenses and improve the bottom line. Over the last three quarters, this company has not done as well producing EPS Growth Rates last quarter, 2 quarters ago and 3 quarters ago -0.83%, 7.10%, 0.32% respectively.

Revenue Growth similar to EPS Growth is also a strong component to consider when screening and scoring for growth companies. Continued growth in revenue shows that the company is innovative, marketable and its products remain relevant in the marketplace. Over the last three quarters, this company has not done as well producing revenue growth rates last quarter, 2 quarters ago and 3 quarters ago 6.22%, 5.94%, 5.14% respectively.

The 5 Year EPS Growth Rate has detracted from the fundamental score with a value of -0.20.

Last quarter this company reported Earnings per Share 0% worse than analysts had expected. We believe this surprise, although only for one quarter, could set a trend for future earnings reports and guidance.

Price relative to earnings growth is commonly referred to as the PEG Ratio. This company may contain added value as its PEG Ratio is 1.15. We generally would like to see the PEG ratio under 1.5 and it is even better if it is under 1.0.

wag2

Horowitz & Company’s proprietary Technical Scoring System (T|score) takes into consideration both individual security technicals as well as the overall market direction when considering whether or not to purchase a company. H&C’s Market Trend Indicator (MTI) is a measure which is designed to evaluate the overall trend in the market. There are four designated levels to assess the trend which include: Strong Downtrend, Downtrend, Rally and Strong Rally. We are currently in an environment where the MTI is in a Strong Downtrend. All of our indicators are showing that the markets are in an unfavorable position for most securities. During this time it is best to only venture into those stocks with the strongest of technicals. It is advisable to invest cautiously during this time frame. With that in mind, this stock ranks in the mid to below average percentile of stocks from an individual security technical score. H&C would not consider purchasing this position in any general market with the exception of a Strong Rally. H&C would be hard pressed to purchase this position even in a Strong Rally considering all other companies that may score higher technically in our growth model.

Below are some of the key technical areas where Walgreen Co (WAG) excelled or detracted from the value of the T|score:

Stochastics are currently showing some bearish attributes which may mean this stock is slightly overbought in the short run.

In terms of price and volume especially over a short period of time it is important to see if there is any weight behind either a rally or correction. The stock has shown to have less than favorable price and volume action and may have a higher potential to move lower if the overall market and economy are to trend lower. Higher volume with negative price also will provide resistance levels for this position if it were to rally back to these levels.

On a 12-month rolling period, this company has not performed as well when comparing against its peers and equities in the S&P 1500. This is often seen as a potential negative sign as it shows weakness relative to the overall market.

H&C currently sees Walgreen Co (WAG) in a Short Term Downtrend and Long Term Uptrend.

wag3

StocktoberFest: CVS Corp. (CVS)

October 1, 2014

CVS1

Horowitz & Company’s proprietary Fundamental Scoring System (F|score) takes into consideration many factors related to each company’s financial history and outlook. This system is oriented toward a growth model and therefore will give a higher score to those companies which continually show increasing earnings per share and revenue over time. Over the long-run (and when looking to purchase a security) we prefer companies with a track record of growth and solid fundamentals. In the short-term however, it is price / technicals that pay. When investing, we combine both of these analyses to seek out possible investment opportunities within our universe of stocks.

This stock ranks below average in fundamentals and would not be considered an option that we would invest in the long-term. For those with a higher risk tolerance, it is possible to enter a speculative position with caution as this market has been much about bottom feeding on the worst of the worst companies. See below for details on where this company thrives and possibly some of the drawbacks:

We find that EPS Growth on a Quarter over Quarter basis is one of the strongest components when screening for growth stocks. Continued EPS Growth in a company generally shows strength in leadership, the ability to manage expenses and improve the bottom line. Over the last three quarters, this company has not done as well producing EPS Growth Rates last quarter, 2 quarters ago and 3 quarters ago 16.48%, 24.36%, -1.87% respectively.

Revenue Growth similar to EPS Growth is also a strong component to consider when screening and scoring for growth companies. Continued growth in revenue shows that the company is innovative, marketable and its products remain relevant in the marketplace. Over the last three quarters, this company has not done as well producing revenue growth rates last quarter, 2 quarters ago and 3 quarters ago 10.73%, 6.30%, 4.56% respectively.

The 5 Year EPS Growth Rate has added to the fundamental score with a value of 11.40.

Last quarter this company reported Earnings per Share 3.01% better than analysts had expected. We believe this surprise, although only for one quarter, could set a trend for future earnings reports and guidance.

Price relative to earnings growth is commonly referred to as the PEG Ratio. This company may contain added value as its PEG Ratio is 1.25. We generally would like to see the PEG ratio under 1.5 and it is even better if it is under 1.0.

cvs2

Horowitz & Company’s proprietary Technical Scoring System (T|score) takes into consideration both individual security technicals as well as the overall market direction when considering whether or not to purchase a company. H&C’s Market Trend Indicator (MTI) is a measure which is designed to evaluate the overall trend in the market. There are four designated levels to assess the trend which include: Strong Downtrend, Downtrend, Rally and Strong Rally. We are currently in an environment where the MTI is in a Strong Downtrend. All of our indicators are showing that the markets are in an unfavorable position for most securities. During this time it is best to only venture into those stocks with the strongest of technicals. It is advisable to invest cautiously during this time frame. With that in mind, this stock ranks in the mid to below average percentile of stocks from an individual security technical score. H&C would not consider purchasing this position in any general market with the exception of a Strong Rally. H&C would be hard pressed to purchase this position even in a Strong Rally considering all other companies that may score higher technically in our growth model.

Below are some of the key technical areas where CVS Health Corp (CVS) excelled or detracted from the value of the T|score:

Stochastics are currently showing some bearish attributes which may mean this stock is slightly overbought in the short run.

During the past two weeks, CVS Health Corp (CVS) has crossed below its 50 day moving average. We see this as a bearish sign as the momentum is starting to change.

In terms of price and volume especially over a short period of time it is important to see if there is any weight behind either a rally or correction. The stock has shown to have less than favorable price and volume action and may have a higher potential to move lower if the overall market and economy are to trend lower. Higher volume with negative price also will provide resistance levels for this position if it were to rally back to these levels.

On a 12-month rolling period, this company has performed very well when comparing against its peers and equities in the S&P 1500. This is a positive sign for this company as it shows strength relative to the overall market.

H&C currently sees CVS Health Corp (CVS) in a Short Term Downtrend and Long Term Downtrend.

cvs3

DHUnplugged #241: Break Out The Gas Masks !

October 1, 2014

Listen Now :
Play


A case of Ebola in the U.S. spooks markets but is great for a few stocks that have potential vaccines. Airline stocks are hit on the news as well.

We discuss the strength of the U.S. dollar and the knock on effects it has for Gold, Silver and other commodities. GoPro (GPRO) is part of our conversation as well as several other stocks of interest.

gasmask

StocktoberFest is coming to The Disciplined Investor.com

See this week’s stock picks HERE.

DHUnplugged #240: Skynet Is Going To Crash Markets

September 24, 2014

Listen Now :
Play


We look at the next possible reason for a stock market crash. Find out more and why this may be already in the works. Inversions are out, markets are worried and much more in this episode.

We also cover, the new iPhone, the most expensive apartment ever and some stocks to watch.

skynet

StocktoberFest is coming to The Disciplined Investor.com

See this week’s stock picks HERE.

DHUnplugged #239: Say Goodbye To The Taxi Industry

September 17, 2014

Listen Now :
Play


So much to discuss. The new iPhone, China’s economic woes, Band Practice, fake beheadings,  and the death of the taxi industry via Uber.

We also spend some time looking at a few stocks, the recent stimulus that is being offered by the bank of China and how the market magically popped today. Let’s not forget about Alibaba….

The lowdown on ISIS or ISIL….

uber

See this week’s stock picks HERE.

Next Page »

Listen Now :
Play


false